Skip to main content
. 2020 Nov 25;6(4):199–204. doi: 10.1016/j.afos.2020.11.004

Table 3.

Outcomes at 1-year follow up.

Variable Before project at 1 year [7] (n = 120) After project at 1 year (n = 273) P-value
Secondary fractures 36 (30.0%) 8 (2.93%) < 0.001∗
Post-injury osteoporotic medications
 No 71 (59.2%) 29 (10.62%) < 0.001∗
 Yes 49 (40.8%) 244 (89.38%)
 Calcium or vitamin D 0 (0.0%) 26 (9.53%)
 Calcium and vitamin D 25 (20.8%) 225 (82.42%)
 Bisphosphonate 18 (15.0%) 15 (5.49%)
 Denosumab 0 (0.0%) 78 (28.57%)
 Teriparatide 6 (5.0%) 29 (10.63%)
 Others (Vit K2, Calcitonin)
0 (0.0%)
7 (2.57%)
Post-injury falls, time NA 0.1 (Min 0, Max 1) NA

Values are presented as number (%).

NA, not assessed; Vit, vitamin; ∗statistically significant.